-
Mashup Score: 0NewsDetails - 3 year(s) ago
NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese During Prostate Cancer Awareness Month the National Comprehensive Cancer Network is announcing up-to-date, translated guidelines featuring recent advances in care for one of the most-common types of cancer, available at NCCN.org/global. PLYMOUTH MEETING, PA [8…
Source: NCCNCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Dr. Berndt utilizes new analytic methods in genetic and molecular epidemiology to elucidate the etiology of cancer and anthropometric traits and explores the impact of modifiable risk factors on cancer risk and mortality.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 0
In 2021, over 248,500 Americans have been diagnosed with prostate cancer. Even as we make tremendous advancements in cancer research and treatment, prostate cancer is the second most commonly diagnosed cancer and the second-leading cause of cancer deaths among our Nation’s fathers, sons, husbands, and brothers. Today, one in eight men in the United States…
Source: The White HouseCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0DCEG Studies of Prostate Cancer - 3 year(s) ago
DCEG is conducting research on prostate cancer.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 5Multiracial Prostate Cancer Study Focuses on Hereditary Factors - 3 year(s) ago
African American men are the most likely to be diagnosed with advanced and incurable prostate cancer and they have a 111% higher risk of dying from it. A City of Hope study co-led by Leanne Burnham, Ph.D., seeks to discover the genetic factors driving prostate cancer in this population.
Source: www.cityofhope.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Prostate exam: How is it done and who should have one? - 4 year(s) ago
Prostate cancer may cause no symptoms, but routine screening can help diagnose it in the early stages, when treatment is most likely to be effective. Here, find out more about what the exam involves.
Source: www.medicalnewstoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis - 4 year(s) ago
To study genetic factors influencing the progression and therapeutic responses of advanced prostate cancer, we developed a fast and flexible system that introduces genetic alterations relevant to human disease directly into the prostate glands of mice using tissue electroporation. These electroporation-based genetically engineered mouse models (EPO-GEMM) recapitulate features of traditional…
Source: Cancer DiscoveryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Michael Cook, Ph.D., focuses on understanding pathogenesis with potential utility for clinical management.
Source: National Cancer InstituteCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 3Making Your Treatment Decision - Prostate Cancer Patient Interview with Andy Schwartz - 4 year(s) ago
(Length of Interview: 2 min) Andy Schwartz, a prostate cancer advocate, and survivor answers a series of questions and explains the importance of seeking information to better prepare yourself for prostate cancer treatment. 1. How did you go about making your treatment decision? 2. Did you feel that you had an adequate understanding of all the pros and cons of each treatment that was available…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Making your treatment decision - #ProstateCancer patient interview. Andy Schwartz explains the importance of seeking information to better prepare yourself for prostate cancer treatment. #WatchNow > https://t.co/Ys4HQRvcPZ #ProstateCancerAwareness @UCSFCancer @charlesryanmd #PCAM https://t.co/QF3SXDC6ZO
-
-
Mashup Score: 0Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database - PubMed - 4 year(s) ago
This study suggests that limited TT exposure does not increase risk of prostate cancer in the short term.
Source: PubMedCategories: Genetics, Latest HeadlinesTweet
Just in time for Prostate Cancer Awareness Month, NCCN shares the latest expert recommendations for Prostate Cancer in Spanish and Portuguese! Learn more on our website: https://t.co/j1HXgyfI6o #NCCNGlobal #ProstateCancerAwarenessMonth #prostatecancerawareness #prostatecancer https://t.co/KQL7lDsXsw